The second is to strengthen rational drug use. Including strengthening drug safety management in medical institutions, improving doctors' clinical level of rational drug use, strengthening the examination of prescriptions by pharmacists or other pharmaceutical technicians, and strengthening rational drug use management and performance evaluation. It is proposed to give priority to the selection of national essential drugs, the centralized procurement and use of drugs organized by the state, and drugs listed in the national medical insurance catalogue. Relevant indicators of rational drug use are included in the performance appraisal system of medical institutions and medical personnel.
The third is to expand the scope of pharmaceutical services. Including strengthening pharmaceutical services in medical institutions, developing community pharmaceutical services and standardizing pharmaceutical services in internet plus. It is necessary to strengthen the allocation of clinical pharmacists and encourage medical institutions to set up pharmaceutical clinics. In order to standardize the management of key links in the online circulation of electronic prescriptions, the personnel who examine, allocate and check electronic prescriptions must adopt electronic signatures or information systems to ensure the traceability of information.
The fourth is to strengthen the construction of pharmaceutical talents. Including strengthening the cultivation of pharmaceutical talents, reasonably embodying the value of pharmaceutical services, and ensuring the reasonable salary and treatment of pharmacists. It is suggested that the cost and value of pharmaceutical services should be considered as a whole in the price of medical services, so as to encourage pharmaceutical personnel to play an active role in promoting rational drug use and reducing resource waste. Medical institutions should reflect the value of technical services in the remuneration of pharmacists. The medical insurance department will incorporate pharmacists' prescription review into the performance appraisal system of designated medical institutions.
The fifth is to improve industry supervision. Including drug monitoring and clinical comprehensive evaluation, strengthening rational drug use supervision, and standardizing drug publicity and pharmacy management in public medical institutions. The National Health and Wellness Commission shall establish a spot check mechanism with relevant departments, and organize spot checks on prescriptions of various provinces (autonomous regions and municipalities) according to a certain proportion every year, and all localities shall correspondingly increase the intensity of spot checks and announcements. Medical institutions should strengthen the management of participating in academic activities involving the promotion of medical consumables.
The sixth is to strengthen organization and implementation. The work requirements are put forward from four aspects: strengthening organizational leadership, strengthening departmental cooperation, strengthening supervision and guidance, and strengthening publicity and guidance. It is pointed out that the management measures of traditional Chinese medicine should be formulated and implemented separately by state administration of traditional chinese medicine in conjunction with relevant departments according to the characteristics of traditional Chinese medicine.
Legal basis: Drug Administration Law of People's Republic of China (PRC) Article 1 This Law is formulated for the purpose of strengthening drug administration, ensuring drug quality, safeguarding the public's drug safety and legitimate rights and interests, and protecting and promoting public health.